New York City Economic Development Corporation (NYCEDC) and Quentis Therapeutics (Quentis), a New York City-based biotechnology company whose first program develops immunotherapy to treat cancer, today announced the completion of the first LifeSci NYC Expansion Space Fund transaction. Become a Harlem Insider! Sign-Up for our Newsletter *Select list(s) to subscribe toHarlem World Magazine Example: Yes, I…